Brazil's Tecpar to test Russian COVID-19 vaccine on 10,000 people in early 2021
- Country:
- Brazil
The technology institute for the Brazilian state of Paraná, which has signed an agreement to produce Russia's Sputnik V coronavirus vaccine, said on Friday it plans to conduct phase III trials on 10,000 volunteers in Brazil at the start of next year.
Jorge Callado, head of Paraná's Technology Institute, known as Tecpar, said approval for the trial will be requested of Brazil's health regulator ANVISA by the end of this month. Doses will be imported for the tests and Tecpar plans to produce the vaccine for Brazil's market in the second half of 2021, he said.
ALSO READ
-
Inside Russia’s SMR School, Where Nuclear Experience Shapes Future Energy Decisions
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
Russia’s Reach Beyond Borders Leaves Exiled Critics Living in Fear, UN Expert Warns
-
Ukraine Faces Another Bitter Winter as UN Inquiry Warns of Deepening Civilian Harm
-
Ukraine War: UN Documents 1,004 Sexual Violence Cases and Calls for Justice
Google News